178 related articles for article (PubMed ID: 33588604)
41. Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
Kanemura H; Go MJ; Shikamura M; Nishishita N; Sakai N; Kamao H; Mandai M; Morinaga C; Takahashi M; Kawamata S
PLoS One; 2014; 9(1):e85336. PubMed ID: 24454843
[TBL] [Abstract][Full Text] [Related]
42. Haplessly hoping: macaque major histocompatibility complex made easy.
Wiseman RW; Karl JA; Bohn PS; Nimityongskul FA; Starrett GJ; O'Connor DH
ILAR J; 2013; 54(2):196-210. PubMed ID: 24174442
[TBL] [Abstract][Full Text] [Related]
43. Multipotent adult germ-line stem cells, like other pluripotent stem cells, can be killed by cytotoxic T lymphocytes despite low expression of major histocompatibility complex class I molecules.
Dressel R; Guan K; Nolte J; Elsner L; Monecke S; Nayernia K; Hasenfuss G; Engel W
Biol Direct; 2009 Aug; 4():31. PubMed ID: 19715575
[TBL] [Abstract][Full Text] [Related]
44. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
[TBL] [Abstract][Full Text] [Related]
45. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
Gaines BA; Colson YL; Kaufman CL; Ildstad S
Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
[TBL] [Abstract][Full Text] [Related]
46. Purified hematopoietic stem cells without facilitating cells can repopulate fully allogeneic recipients across entire major histocompatibility complex transplantation barrier in mice.
Wang By; El-Badri NS; Cherry ; Good RA
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14632-6. PubMed ID: 9405664
[TBL] [Abstract][Full Text] [Related]
47. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
48. Generation of individualized immunocompatible endothelial cells from HLA-I-matched human pluripotent stem cells.
Song C; Wang L; Li Q; Liao B; Qiao W; Li Q; Dong N; Li L
Stem Cell Res Ther; 2022 Feb; 13(1):48. PubMed ID: 35109922
[TBL] [Abstract][Full Text] [Related]
49. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.
Pezzanite LM; Fortier LA; Antczak DF; Cassano JM; Brosnahan MM; Miller D; Schnabel LV
Stem Cell Res Ther; 2015 Apr; 6(1):54. PubMed ID: 25889095
[TBL] [Abstract][Full Text] [Related]
50. The tumourigenicity of iPS cells and their differentiated derivates.
Liu Z; Tang Y; Lü S; Zhou J; Du Z; Duan C; Li Z; Wang C
J Cell Mol Med; 2013 Jun; 17(6):782-91. PubMed ID: 23711115
[TBL] [Abstract][Full Text] [Related]
51. Efficient Generation of Induced Pluripotent Stem and Neural Progenitor Cells From Acutely Harvested Dura Mater Obtained During Ventriculoperitoneal Shunt Surgery.
Cary WA; Hori CN; Pham MT; Nacey CA; McGee JL; Hamou M; Berman RF; Bauer G; Nolta JA; Waldau B
World Neurosurg; 2015 Nov; 84(5):1256-66.e1. PubMed ID: 26074438
[TBL] [Abstract][Full Text] [Related]
52. Molecular imaging of induced pluripotent stem cell immunogenicity with in vivo development in ischemic myocardium.
Liu Z; Wen X; Wang H; Zhou J; Zhao M; Lin Q; Wang Y; Li J; Li D; Du Z; Yao A; Cao F; Wang C
PLoS One; 2013; 8(6):e66369. PubMed ID: 23840453
[TBL] [Abstract][Full Text] [Related]
53. Adaptation of HLA testing to characterize the cynomolgus macaque MHC polymorphisms and alloantibody signatures.
Agarwal D; Liu C; Bhoj V; Kearns J; Bharani T; Choe I; Vivek K; O'Connor DH; Wiseman RW; Duquesnoy RJ; Naji A; Kamoun M
HLA; 2024 Jan; 103(1):e15239. PubMed ID: 37784210
[TBL] [Abstract][Full Text] [Related]
54. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
55. Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model.
Hong SG; Winkler T; Wu C; Guo V; Pittaluga S; Nicolae A; Donahue RE; Metzger ME; Price SD; Uchida N; Kuznetsov SA; Kilts T; Li L; Robey PG; Dunbar CE
Cell Rep; 2014 May; 7(4):1298-1309. PubMed ID: 24835994
[TBL] [Abstract][Full Text] [Related]
56. Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications.
Wu HL; Weber WC; Shriver-Munsch C; Swanson T; Northrup M; Price H; Armantrout K; Robertson-LeVay M; Reed JS; Bateman KB; Mahyari E; Thomas A; Junell SL; Hobbs TR; Martin LD; MacAllister R; Bimber BN; Slifka MK; Legasse AW; Moats C; Axthelm MK; Smedley J; Lewis AD; Colgin L; Meyers G; Maziarz RT; Burwitz BJ; Stanton JJ; Sacha JB
Xenotransplantation; 2020 Jul; 27(4):e12578. PubMed ID: 31930750
[TBL] [Abstract][Full Text] [Related]
57. Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice.
Sun YQ; Zhang Y; Li X; Deng MX; Gao WX; Yao Y; Chiu SM; Liang X; Gao F; Chan CW; Tse HF; Shi J; Fu QL; Lian Q
Stem Cells; 2015 Dec; 33(12):3452-67. PubMed ID: 26175298
[TBL] [Abstract][Full Text] [Related]
58. Generation of induced pluripotent stem cells as a potential source of hematopoietic stem cells for transplant in PNH patients.
Phondeechareon T; Wattanapanitch M; U-Pratya Y; Damkham C; Klincumhom N; Lorthongpanich C; Kheolamai P; Laowtammathron C; Issaragrisil S
Ann Hematol; 2016 Oct; 95(10):1617-25. PubMed ID: 27465155
[TBL] [Abstract][Full Text] [Related]
59. Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases.
Sugai K; Fukuzawa R; Shofuda T; Fukusumi H; Kawabata S; Nishiyama Y; Higuchi Y; Kawai K; Isoda M; Kanematsu D; Hashimoto-Tamaoki T; Kohyama J; Iwanami A; Suemizu H; Ikeda E; Matsumoto M; Kanemura Y; Nakamura M; Okano H
Mol Brain; 2016 Sep; 9(1):85. PubMed ID: 27642008
[TBL] [Abstract][Full Text] [Related]
60. Generation and characterization of cynomolgus monkey kidney fibroblasts (cmKF)-derived induced pluripotent stem cells (cmKF-iPS-C5).
Zhen X; Kang W; Park SJ; Choe SH; Hong SH; Lee DS; Lee JH
Stem Cell Res; 2022 Oct; 64():102887. PubMed ID: 35944314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
